Tracie buys AKRX 29.77: Akorn Shares Gaining On $41 Million Sale Of Branded Drugs Unit To Valeant
Akorn (NASDAQ: AKRX) sold its branded drug unit for $41 million and saw its shares gain nearly four percent Friday morning. The unit, ECR Pharmaceuticals, went to Valeant Pharmaceuticals (NYSE: VRX) for a combination of $41 million cash and debt ... ...
51 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home